Unigene Laboratories Inc

Unigene’s patented peptide expression technology utilises the E. coli general secretory pathway.which provides for the cost effective production of peptides. Recombinant expression of peptide hormones of 25 amino acids or greater offers the potential to be more cost effective and environmentally acceptable when compared with current chemical synthesis methods. This advantage is particularly important when hundreds of kilograms of product are required per year and Unigene’s 1000 litre bacterial fermentor for production of peptides and glycine-extended peptide precursors supports ongoing research and development activities.

Further Information: http://www.unigene.com/